Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.

AIM: Occasional findings of anti-cyclic-citrullinated-protein-antibodies (anti-CCP) were rarely observed in psoriatic arthritis (PsA). The aim of our study is to evaluate whether the presence of anti-CCP can determine different clinical subsets and influence methotrexate monotherapy survival, and bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotondo, Cinzia, Corrado, Addolorata, Cici, Daniela, Berardi, Stefano, Cantatore, Francesco Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970688/
https://www.ncbi.nlm.nih.gov/pubmed/33796242
http://dx.doi.org/10.1177/2040622320986722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970688/
https://www.ncbi.nlm.nih.gov/pubmed/33796242
http://dx.doi.org/10.1177/2040622320986722

Ejemplares similares